Allscripts (MDRX) Misses Q1 EPS by 6c, Revenues Miss; Withdraws FY20 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Allscripts Announces First Quarter 2020 Results
May 7, 2020 4:01 PM EDTFirst quarter 2020 bookings of $205 million, above high end of outlook range
CHICAGO--(BUSINESS WIRE)-- Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX) (Allscripts) announced its financial results for the three months ended March 31, 2020.
Bookings(1) were $205 million in the first quarter of 2020. This result compares with $286 million in the first quarter of 2019. Contract revenue backlog totaled $4.5 billion as of March 31, 2020.
First quarter 2020 revenue was $417 million compared with $432 million in the first quarter of 2019.
On a GAAP basis in the first quarter of 2020 total operating expenses were $166... More
